Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023 ...Middle East

PR Newswire - News
Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023
MUMBAI, India, Nov. 9, 2022 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2022. Consolidated Financial Highlights...

Hence then, the article about piramal pharma limited announces consolidated results for q2 and h1 fy2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023 )

Apple Storegoogle play

Last updated :

Also on site :